Acrivon Therapeutics Inc

ACRV NASDAQ Santé & Biotech États-Unis US0048901096
1.49 $
1.97 %

Acrivon Therapeutics Inc est une société biopharmaceutique axée sur le développement de médicaments innovants ciblant le cancer et d'autres maladies graves.

Performance & Momentum

6 Months 35.50 %
1 Year 23.14 %
3 Years 88.40 %
5 Years 90.56 %

Similar stocks to Acrivon Therapeutics Inc

Anantys Community

Be the first to share your analysis on Acrivon Therapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases